Back to Search Start Over

Predictors of mid-term outcomes in patients undergoing implantation of a ventricular assist device directly after extracorporeal life support.

Authors :
Tsyganenko, Dmytro
Gromann, Tom Wolfgang
Schoenrath, Felix
Mueller, Marcus
Mulzer, Johanna
Starck, Christoph
Krabatsch, Thomas
Stein, Julia
Falk, Volkmar
Potapov, Evgenij
Source :
European Journal of Cardio-Thoracic Surgery. Apr2019, Vol. 55 Issue 4, p773-779. 7p.
Publication Year :
2019

Abstract

View large Download slide View large Download slide OBJECTIVES Extracorporeal life support (ECLS) can be applied as a bridge to diagnosis and decision-making for further treatment with long-term left ventricular assist devices (LVADs). METHODS From January 2012 to January 2018, 714 adult patients were treated with ECLS in our institution. During the same period, 618 patients received an LVAD for long-term support. Of them, 100 patients were further supported with a long-term LVAD. We retrospectively analysed the datasets of these 100 consecutive patients with the goal of developing an algorithm to predict outcomes for a rational use of long-term ventricular assist device therapy in this setting. RESULTS The mean age of the 100 patients was 54.1 ± 11.6 years, and 72 were men. Twenty-nine patients had a BMI of >30 kg/m2. In 33 patients, a temporary right ventricular assist device was necessary postoperatively. The 30-day, 1-year and 2-year survival after ventricular assist device implantation was 62.0% [95% confidence interval (CI) 53.2–72.3], 43.0% (95% CI 34.3–53.9) and 37.1% (95% CI 28.2–48.7%), respectively. Penalized multivariable logistic regression analysis showed following predictors for 1-year mortality: bilirubin increase per mg/dl [odds ratio (OR) 1.41, 95% CI 1.12–1.77], C-reactive protein increase per mg/dl (OR 1.11, 95% CI 1.05–1.19), ECLS duration >7 days (OR 4.90, 95% CI 1.66–14.41), BMI >30 kg/m2 (OR 1.41, 95% CI 1.05–8.52) and female gender (OR 3.06, 95% CI 1.02–9.23). On the basis of these data, a nomogram to estimate 1-year mortality after LVAD implantation was created. CONCLUSIONS After stabilization of patients experiencing cardiogenic shock using ECLS, LVAD implantation can be performed with elevated mortality in an otherwise futile situation. Liver dysfunction, inflammatory status and obesity increase the risk for mid-term mortality. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10107940
Volume :
55
Issue :
4
Database :
Academic Search Index
Journal :
European Journal of Cardio-Thoracic Surgery
Publication Type :
Academic Journal
Accession number :
135430928
Full Text :
https://doi.org/10.1093/ejcts/ezy351